AKT1 and melanoma: CDKN1B was shown to be downregulated and the PI3K/AKT pathway activated in primary melanoma cells after exosomal transfer of miR-222, which was accompanied by increased proliferation and induced invasive and chemotactic capabilities in primary melanoma cells [52].